Upregulation of vitamin D-related genes in schizophrenic patients

References

• EscuderoIJohnstoneMGenetics of schizophreniaCurr Psychiatry Rep2014161150225200985
   PubMed Web of Science ®Google Scholar
• AmaralADCalhauCCoelhoRSchizophrenia: implications of vitamin D deficit on brain developmentIJCNMH2014116114
   Google Scholar
• CieslakKFeingoldJAntoniusDLow vitamin D levels predict clinical features of schizophreniaSchizophr Res20141592–354354525311777
   PubMed Web of Science ®Google Scholar
• YükselRNAltunsoyNTikirBCorrelation between total vitamin D levels and psychotic psychopathology in patients with schizophrenia: therapeutic implications for add-on vitamin D augmentationTher Adv Psychopharmacol20144626827525489478
   PubMedGoogle Scholar
• EylesDAlmerasLBenechPDevelopmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brainJ Steroid Biochem Mol Biol20071033–553854517293106
   PubMed Web of Science ®Google Scholar
• ProsserDEJonesGEnzymes involved in the activation and inactivation of vitamin DTrends Biochem Sci2004291266467315544953
   PubMed Web of Science ®Google Scholar
• GrovesNJMcGrathJJBurneTHVitamin D as a neurosteroid affecting the developing and adult brainAnnu Rev Nutr20143411714125033060
   PubMed Web of Science ®Google Scholar
• SchusterICytochromes P450 are essential players in the vitamin D signaling systemBiochim Biophys Acta20111814118619920619365
   PubMed Web of Science ®Google Scholar
• DelucaGCKimballSMKolasinskiJRamagopalanSVEbersGCReview: the role of vitamin D in nervous system health and diseaseNeuropathol Appl Neurobiol201339545848423336971
   PubMed Web of Science ®Google Scholar
• RahimiSSayadAMoslemiEGhafouri-FardSTaheriMBlood assessment of the expression levels of matrix metalloproteinase 9 (MMP9) and its natural inhibitor, TIMP1 genes in Iranian schizophrenic patientsMetab Brain Dis20173251537154228578515
   PubMed Web of Science ®Google Scholar
• AzimiTGhafouri-FardSDavood OmraniMVaccinia related kinase 2 (VRK2) expression in neurological disorders: schizophrenia, epilepsy and multiple sclerosisMult Scler Relat Disord201819151929100046
   PubMed Web of Science ®Google Scholar
• Nafisi-FarNGhafouri-FardSPanahASTSayadATaheriMA gender dimorphism in up-regulation of BACE1 gene expression in schizophreniaMetab Brain Dis201833393393729500546
   PubMed Web of Science ®Google Scholar
• KulkarniJRiedelAde CastellaAREstrogen – a potential treatment for schizophreniaSchizophr Res200148113714411278160
   PubMed Web of Science ®Google Scholar
• PatrickRPAmesBNVitamin D hormone regulates serotonin synthesis. Part 1: relevance for autismFASEB J20142862398241324558199
   PubMed Web of Science ®Google Scholar
• PatrickRPAmesBNVitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behaviorFASEB J20152962207222225713056
   PubMed Web of Science ®Google Scholar
• KuningasMMooijaartSPJollesJSlagboomPEWestendorpRGvan HeemstDVDR gene variants associate with cognitive function and depressive symptoms in old ageNeurobiol Aging200930346647317714831
   PubMed Web of Science ®Google Scholar
• AhmadiSMirzaeiKHossein-NezhadAShariatiGVitamin D receptor FokI genotype may modify the susceptibility to schizophrenia and bipolar mood disorder by regulation of dopamine D1 receptor gene expressionMinerva Med2012103538339123042374
   PubMed Web of Science ®Google Scholar
• NerhusMBergAOKvitlandLRLow vitamin D is associated with negative and depressive symptoms in psychotic disordersSchizophr Res20161781–3444927595553
   PubMed Web of Science ®Google Scholar
• SmoldersJThewissenMTheunissenRVitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosisJ Neuroimmunol20112351–2919721507492
   PubMed Web of Science ®Google Scholar
• FatemiSHFolsomTDReutimanTJNovakJEngelRHComparative gene expression study of the chronic exposure to clozapine and haloperidol in rat frontal cortexSchizophr Res20121342–321121822154595
   PubMed Web of Science ®Google Scholar
• LeeBJMarchionniLAndrewsCEAnalysis of differential gene expression mediated by clozapine in human postmortem brainsSchizophr Res2017185586628038920
   PubMed Web of Science ®Google Scholar
• KoradeŽLiuWWarrenEBArmstrongKPorterNAKonradiCEffect of psychotropic drug treatment on sterol metabolismSchizophr Res2017187748128202290
   PubMed Web of Science ®Google Scholar
• HolmøyTMoenSMGundersenTA25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosisMult Scler200915111280128519808741
   PubMed Web of Science ®Google Scholar
• SmoldersJSchuurmanKGvan StrienMEExpression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissueJ Neuropathol Exp Neurol20137229110523334593
   PubMed Web of Science ®Google Scholar
• DoKQCabungcalJHFrankASteulletPCuenodMRedox dysregulation, neurodevelopment, and schizophreniaCurr Opin Neurobiol200919222023019481443
   PubMed Web of Science ®Google Scholar
• BerridgeMJVitamin D cell signalling in health and diseaseBiochem Biophys Res Commun20154601537125998734
   PubMed Web of Science ®Google Scholar
• GarcionESindjiLLeblondelGBrachetPDarcyF1,25-dihy-droxyvitamin D3 regulates the synthesis of gamma-glutamyl transpep-tidase and glutathione levels in rat primary astrocytesJ Neurochem199973285986610428085
   PubMed Web of Science ®Google Scholar
• KogaMSerritellaAVSawaASedlakTWImplications for reactive oxygen species in schizophrenia pathogenesisSchizophr Res20161761527126589391
   PubMed Web of Science ®Google Scholar
• SteulletPCabungcalJMoninARedox dysregulation, neuroinflammation, and NMDA receptor hypofunction: a “central hub” in schizophrenia pathophysiology?Schizophr Res20161761415125000913
   PubMed Web of Science ®Google Scholar
• GarcionEWion-BarbotNMontero-MeneiCNBergerFWionDNew clues about vitamin D functions in the nervous systemTrends Endocrinol Metab200213310010511893522
   PubMed Web of Science ®Google Scholar
• SnyderMAGaoWJNMDA hypofunction as a convergence point for progression and symptoms of schizophreniaFront Cell Neurosci201373123543703
   PubMed Web of Science ®Google Scholar
• BitanihirweBKWooTUOxidative stress in schizophrenia: an integrated approachNeurosci Biobehav Rev201135387889320974172
   PubMed Web of Science ®Google Scholar
• MüllerNUlmschneiderMScheppachCCOX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapyEur Arch Psychiatry Clin Neurosci20042541142214991374
   PubMed Web of Science ®Google Scholar
• WangQHeYShenYVitamin D inhibits COX-2 expression and inflammatory response by targeting thioesterase superfamily member 4J Biol Chem201428917116811169424619416
   PubMed Web of Science ®Google Scholar
• KrivoyAHochmanESendtKVAssociation between serum levels of glutamate and neurotrophic factors and response to clozapine treatmentSchizophr Res201819222623128599751
   PubMed Web of Science ®Google Scholar